BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.EBI
Ewha Womans University
Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.EBI
Genkyotex
First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.EBI
Genkyotex
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors.EBI
TBA
A closer look at NEBI
Monash University Malaysia
Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.EBI
University of Pittsburgh
Ethynyl derivativesBDB
Hoffmann-La Roche
Heteroaryl compounds as inhibitors of TYK2, composition and application thereofBDB
Accro Bioscience (HK)
N/O-Linked Degrons and Degronimers for Protein DegradationBDB
C4 Therapeutics
Biaryl amide compounds as kinase inhibitorsBDB
Novartis
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2BBDB
Cadent Therapeutics
C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their useBDB
TBA
Inhibitors of protein tyrosine phosphatasesBDB
Indiana University Research and Technology
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesBDB
Abbvie
Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase.BDB
Friedrich Alexander University Erlangen
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.BDB
Bristol-Myers Squibb
Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors.BDB
University of Liverpool
Toward an optimal joint recognition of the S1' subsites of endothelin converting enzyme-1 (ECE-1), angiotensin converting enzyme (ACE), and neutral endopeptidase (NEP).BDB
Cnrs
Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2.BDB
University of Athens
Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.BDB
Universita Degli Studi Di Bari
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.BDB
Wyeth Research
Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.BDB
Toronto General Research Institute